SMTL ID : 7yc9.1

Co-crystal structure of BTK kinase domain with inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

monomer

Ligands

1 x IS4: (7~{S})-2-(4-bromanyl-3,5-dimethoxy-phenyl)-7-(1-propanoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide(Covalent)

IS4.1: 19 residues within 4Å: Chain A: L.18, T.20, V.26, A.38, I.39, K.40, I.82, T.84, E.85, Y.86, M.87, G.90, C.91, N.94, R.135, L.138, S.148, F.150, Y.155 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.138, A:L.138 Hydrogen bonds: A:T.84, A:E.85, A:M.87, A:M.87, A:N.94, A:S.148 pi-Cation interactions: A:K.40

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 3 residues within 4Å: Chain A: K.16, E.17, K.27 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.17

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Guo, Y. et al., Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase for B-Cell Malignancies and Autoimmune Diseases. J.Med.Chem. (2023)

Release Date

2023-05-17

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence